Percutaneous Endoluminal Radiofrequency Ablation of Occluded Biliary Metal Stent in Malignancy Using Monopolar Technique: A Feasibility Study
Language English Country United States Media print-electronic
Document type Journal Article
Grant support
NU21-08-00561
Ministerstvo Zdravotnictví Ceské Republiky
PubMed
35217890
DOI
10.1007/s00270-022-03097-z
PII: 10.1007/s00270-022-03097-z
Knihovny.cz E-resources
- Keywords
- Biliary malignancy, Biliary stenosis, Intraductal ablation, Metal stent, Monopolar technique, Radiofrequency ablation,
- MeSH
- Cholestasis * diagnostic imaging etiology surgery MeSH
- Catheter Ablation * methods MeSH
- Humans MeSH
- Bile Duct Neoplasms * surgery MeSH
- Radiofrequency Ablation * MeSH
- Retrospective Studies MeSH
- Stents adverse effects MeSH
- Feasibility Studies MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
PURPOSE: To prove feasibility and safety of percutaneous endoluminal radiofrequency ablation (eRFA) using a monopolar approach in treatment of occluded biliary stent in malignancy. MATERIALS AND METHODS: The study included 11 patients with occluded biliary metal stent that had been implanted due to malignant biliary obstruction. All underwent metal stent recanalization by percutaneous eRFA in monopolar setting. Sixteen eRFA procedures were performed under fluoroscopic guidance with an EndoHPB 8F radiofrequency ablation catheter. The effect of stent recanalization was assessed based upon change from pre- to post-procedural diameter of the patent lumen of the metal stent (Wilcoxon test), primary and secondary stent patency (compared by log-rank test), catheter-free period, and overall survival. Adverse events were evaluated according to Common Terminology Criteria for Adverse Events (CTCEA) 4.0. RESULTS: Recanalization of the metal stent by monopolar radiofrequency ablation was successful in all 11 patients. Diameter of the patent lumen of the stent significantly widened after the eRFA inside the stent (median 2 vs. 7 mm, p = 0.003). Grade 1 complications were observed in one-third of procedures. Median stent patency after recanalization by eRFA was non-inferior to primary metal stent patency (154 vs. 161 days, p = 0.27). Median catheter-free survival and overall survival after stent recanalization were 149 and 210 days, respectively. CONCLUSION: Endoluminal radiofrequency ablation in monopolar setting was shown to be a feasible and safe method for recanalization of occluded biliary metal stents. LEVEL OF EVIDENCE: Level 4, Case Series.
See more in PubMed
Pai M, Valek V, Tomas A, Doros A, Quaretti P, Golfieri R, et al. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2014;37:235–40. DOI
Lossef SV, Druy E, Jelinger E, Fleischer D, Barth KH. Use of hot-tip laser probes to recanalize occluded expandable metallic biliary endoprostheses. Am J Roentgenol. 1992;158:199–201. DOI
Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–53. DOI
Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I, et al. Interventional radiofrequency ablation: a promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction. J Cancer. 2018;9:629–37. DOI
Bernard V, Andrašína T, Mornstein V, Válek V. Radiofrequency tissue ablation inside of metal stent—a thermographic study. IRBM. 2014;35:164–9. DOI
Wu T-T, Li H-C, Li W-M, Ao G-K, Lin H, Zheng F, et al. Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction: a safe and feasible method. Dig Dis Sci. 2015;60:2158–63. DOI
Lee JM, Han JK, Kim SH, Sohn KL, Lee KH, Ah SK, et al. A comparative experimental study of the in-vitro efficiency of hypertonic saline-enhanced hepatic bipolar and monopolar radiofrequency ablation. Korean J Radiol. 2003;4:163. DOI
Goldberg SN, Ryan TP, Hahn PF, Schima W, Dawson SL, Lawes KR, et al. Transluminal radiofrequency tissue ablation with use of metallic stents. J Vasc Interv Radiol. 1997;8:835–43. DOI
Mizandari M, Pai M, Xi F, Valek V, Tomas A, Quaretti P, et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2013;36:814–9. DOI
Xia N, Gong J, Lu J, Chen Z-J, Zhang L-Y, Wang Z-M. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: a preliminary result. World J Gastroenterol. 2017;23:1851–6. DOI
Inoue T, Ito K, Yoneda M. Novel balloon catheter-based endobiliary radiofrequency ablation system: ex-vivo experimental study. Dig Endosc. 2020;32:974–8. DOI
Rohan T, Andrasina T, Juza T, Matkulcik P, Červinka D, Svobodova I, et al. Experimental model of occluded biliary metal stent recanalization using irreversible electroporation via a tubular catheter. Int J Hyperthermia. Taylor & Francis; 2021;38:393–401.